Actively Recruiting
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Led by Christoph Aufricht · Updated on 2023-12-08
100
Participants Needed
1
Research Sites
573 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Nephrotic syndrome is the clinical phenotype of a heterogeneous group of glomerular diseases that may present with varying degrees of urinary protein loss (proteinuria), dysproteinemia in the blood, fluid retention and impaired renal function. The AustRian RESistanT NEPHROtic Syndrome Treatment Response RegIStry and Biobank (ARREST-NEPHROSIS) sets out to achieve the following goals, as typical categories of rare disease registries 1. Obtaining real world data on practice patterns and outcomes 2. Networking between affected patients, families, and clinicians. 3. Establish a patient base for facilitated recruitment in studies of drugs, medical devices, and products 4. Development of a Biobank to enable research of potential biomarkers and therapy or disease courses
CONDITIONS
Official Title
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Resistant to standard Immunosuppressive agents (if clinically indicated, e.g. primary/non-genetic forms)
- Persistent urinary protein-to-creatinine (UP/C) ratio >1.0 g/g
- eGFR > 30 ml/min per 1.73 m2
- Biopsy or a disease-causing genetic mutation associated with nephrotic syndrome
You will not qualify if you...
- Inability or unwillingness to comply with repeated assessments
- Objections against participation at discretion of the investigator
- Secondary nephrotic syndrome
- Patients with steroid-dependence or frequently relapsing disease (but achievement of complete remission)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, 1090 Vienna, Austria.
Vienna, Austria, 1090
Actively Recruiting
Research Team
C
Christoph Aufricht, Prof. MD
CONTACT
L
Lisa Daniel-Fischer, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here